Cart
sales@molnova.com
AG 99
CAS No. 122520-85-8
AG 99( (E)-Tyrphostin AG 99 | (E)-Tyrphostin 46 | Tyrphostin 46 )
Catalog No. M19940 CAS No. 122520-85-8
AG-99 is an inhibitor of EGFR kinase (IC50: 10 μM in the human epidermoid carcinoma cell line A431).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 42 | In Stock |
|
| 10MG | 33 | In Stock |
|
| 25MG | 59 | In Stock |
|
| 50MG | 82 | In Stock |
|
| 100MG | 114 | In Stock |
|
| 200MG | 166 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAG 99
-
NoteResearch use only, not for human use.
-
Brief DescriptionAG-99 is an inhibitor of EGFR kinase (IC50: 10 μM in the human epidermoid carcinoma cell line A431).
-
DescriptionAG-99 is an inhibitor of EGFR kinase (IC50: 10 μM in the human epidermoid carcinoma cell line A431).
-
In Vitro(E)-AG 99 effectively blocks tyrosine phosphorylation of p145met and promotes cell death accompanied by activation of caspase-like proteases.
-
In Vivo——
-
Synonyms(E)-Tyrphostin AG 99 | (E)-Tyrphostin 46 | Tyrphostin 46
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number122520-85-8
-
Formula Weight204.18
-
Molecular FormulaC10H8N2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 20 mg/mL;Ethanol: 1 mg/mL;Water: Insoluble
-
SMILESNC(=O)C(=C\c1ccc(O)c(O)c1)\C#N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gazit A et al. Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro. J Med Chem. 1996 Dec 6;39(25):4905-11.
molnova catalog
related products
-
AZD8931 diFuMaric ac...
AZD8931 is a reversible and ATP competitive inhibitor of EGFR, ErbB2 and ErbB3 (IC50 of 4 nM, 3 nM and 4 nM, respectively).AZD8931 significantly suppressed cell growth of IBC cells and induced apoptosis of human IBC cells in vitro.AZD8931 monotherapy inhibited xenograft growth.
-
Dacomitinib
Dacomitinib (PF-00299804, PF-299804) is a potent, irreversible, orally active pan-ErbB receptor tyrosine kinase inhibitor with IC50 of 6, 45.7 and 73.7 for EGFR, ERBB2 and ERBB4, respectively.
-
JCN037
JCN037 is potent, non-covalent and brain-penetrant inhibitor of EGFR(EGFR, p-wtEGFR and pEGFRvⅢ with IC50 of 2.49 nM, 3.95 nM, 4.48 nM , respectively).
